日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer

一项针对晚期胰腺癌或结直肠癌患者的BMS-813160（一种CCR2/5双重拮抗剂）联合化疗或纳武利尤单抗的1b/2期研究

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-011284
Le, Dung T; Folprecht, Gunnar; Varghese, Anna M; Gutierrez, Martin; Noel, Marcus; Trikalinos, Nikolaos A; Chen, Eric; Dayyani, Farshid; Davis, S Lindsey; Ma, Wen Wee; BasuMallick, Atrayee; Garrido-Laguna, Ignacio; Osawa, Mayu; O'Brien, Shaun; Novosiadly, Ruslan D; Xu, Ke; Greenawalt, Danielle M; Dutta, Santanu; Twyman Saint Victor, Christina; Lenz, Heinz-Josef
CR2
肿瘤
肠癌
肿瘤免疫
多发性硬化症
胰腺癌
发表日期：2026
文献求助 收藏

Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumors

BMS-986299（一种 NLRP3 激动剂）单药治疗以及与纳武利尤单抗和伊匹木单抗联合治疗晚期实体瘤患者的 I 期研究

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-010013
Nelson, Blessie E; O'Brien, Shaun; Sheth, Rahul A; Hong, David S; Naing, Aung; Zhang, Xiaoping; Xu, Amy; Hamuro, Lora; Suryawanshi, Rasika; McKinley, Derrick; Novosiadly, Ruslan D; Piha-Paul, Sarina A
NLRP3
LRP3
多发性硬化症
发表日期：2025
文献求助 收藏

Endorsing a Hidden Plasmonic Mode for Enhancement of LSPR Sensing Performance in Evolved Metal-insulator Geometry Using an Unsupervised Machine Learning Algorithm

利用无监督机器学习算法，在演化金属-绝缘体几何结构中增强隐藏等离子体模式的LSPR传感性能

期刊:ACS Physical Chemistry Au
影响因子:4.3
doi:10.1021/acsphyschemau.2c00033
Bhalla, Nikhil; Thakur, Atul; Edelman, Irina S; Ivantsov, Ruslan D
发表日期：2022
文献求助 收藏

Analysis of Polarization Images in the Microphysical Blood Parameters Research for the Hematocrit Diagnostics

微物理血液参数研究中偏振图像的分析及其在血细胞比容诊断中的应用

期刊:Micromachines
影响因子:3
doi:10.3390/mi13122241
Khlynov, Ruslan D; Ryzhova, Victoria A; Yarishev, Sergey N; Konyakhin, Igor A; Korotaev, Valery V; Shelepin, Yuri E; Djamiykov, Todor S; Marinov, Marin B
细胞生物学
发表日期：2022
文献求助 收藏

Effects of Alpha-2 Adrenergic Agonist Mafedine on Brain Electrical Activity in Rats after Traumatic Brain Injury

α2肾上腺素能激动剂马非丁对创伤性脑损伤大鼠脑电活动的影响

期刊:Brain Sciences
影响因子:2.8
doi:10.3390/brainsci11080981
Sysoev, Yuriy I; Prikhodko, Veronika A; Chernyakov, Roman T; Idiyatullin, Ruslan D; Musienko, Pavel E; Okovityi, Sergey V
Rat
神经科学
免疫/内分泌
发表日期：2021
文献求助 收藏

SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery

SITC癌症免疫疗法资源文件：生物标志物发现领域的指南针

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2020-000705
Hu-Lieskovan, Siwen; Bhaumik, Srabani; Dhodapkar, Kavita; Grivel, Jean-Charles J B; Gupta, Sumati; Hanks, Brent A; Janetzki, Sylvia; Kleen, Thomas O; Koguchi, Yoshinobu; Lund, Amanda W; Maccalli, Cristina; Mahnke, Yolanda D; Novosiadly, Ruslan D; Selvan, Senthamil R; Sims, Tasha; Zhao, Yingdong; Maecker, Holden T
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2020
文献求助 收藏

Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients

结直肠癌患者对西妥昔单抗的内在和获得性耐药性的基因组表征

期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-019-51981-5
Steven M Bray, Jeeyun Lee, Seung Tae Kim, Joon Young Hur, Philip J Ebert, John N Calley, Isabella H Wulur, Thejaswini Gopalappa, Swee Seong Wong, Hui-Rong Qian, Jason C Ting, Jiangang Liu, Melinda D Willard, Ruslan D Novosiadly, Young Suk Park, Joon Oh Park, Ho Yeong Lim, Won Ki Kang, Amit Aggarwal,
肿瘤
肠癌
发表日期：2019
文献求助 收藏

Correction to: Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054

更正：拮抗剂抗PD-L1单克隆抗体LY3300054的发现和临床前表征

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1186/s40425-018-0354-6
Li, Yiwen; Carpenito, Carmine; Wang, George; Surguladze, David; Forest, Amelie; Malabunga, Maria; Murphy, Mary; Zhang, Yiwei; Sonyi, Andreas; Chin, Darin; Burtrum, Douglas; Inigo, Ivan; Pennello, Anthony; Shen, Leyi; Malherbe, Laurent; Chen, Xinlei; Hall, Gerald; Haidar, Jaafar N; Ludwig, Dale L; Novosiadly, Ruslan D; Kalos, Michael
单克隆抗体
PD-L1
发表日期：2018
文献求助 收藏

Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade

galunisertib（一种 TGFβRI 小分子抑制剂）靶向 TGFβ 通路，可促进抗肿瘤免疫，从而产生持久、完全的缓解，可作为单一疗法或与检查点阻断联合使用

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.3
doi:10.1186/s40425-018-0356-4
Rikke B Holmgaard, David A Schaer, Yanxia Li, Stephen P Castaneda, Mary Y Murphy, Xiaohong Xu, Ivan Inigo, Julie Dobkin, Jason R Manro, Philip W Iversen, David Surguladze, Gerald E Hall, Ruslan D Novosiadly, Karim A Benhadji, Gregory D Plowman, Michael Kalos, Kyla E Driscoll
免疫
肿瘤
Checkpoint
发表日期：2018
文献求助 收藏

Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054

拮抗性抗PD-L1单克隆抗体LY3300054的发现及临床前表征

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.3
doi:10.1186/s40425-018-0329-7
Yiwen Li, Carmine Carpenito, George Wang, David Surguladze, Amelie Forest, Maria Malabunga, Mary Murphy, Yiwei Zhang, Andreas Sonyi, Darin Chin, Douglas Burtrum, Ivan Inigo, Anthony Pennello, Leyi Shen, Laurent Malherbe, Xinlei Chen, Gerald Hall, Jaafar N Haidar, Dale L Ludwig, Ruslan D Novosiadly, 
PD-L1
单克隆抗体
发表日期：2018
文献求助 收藏